BioSpace News Archive

Business

Myriad to Announce Fiscal Second-Quarter 2020 Financial Results on February 6, 2020

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that it will hold its fiscal second-quarter 2020 sales and earnings conference call with investors and analysts at 4:30 p.m. ET on Thursday, February 6, 2020.

January 30, 2020
·
2 min read
Business

Anavex Life Sciences to Announce Fiscal 2020 First Quarter Financial Results on Thursday, February 6th, 2020Conference Call and Webcast To be Held Thursday, February 6, 2020 4:30pm Eastern Time

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced that it will issue financial results for its fiscal quarter ended December 31, 2019 on Thursday, February 6th, 2020.

January 30, 2020
·
3 min read
Deals

Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell’s Gene Editing Platform and Oncology Product Portfolio

Transaction adds comprehensive gene editing capabilities and engine to drive expansion of Abcam’s ‘off-the-shelf’ edited cell line portfolio

January 30, 2020
·
4 min read
Business

Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development as it commits to a $100M investment in building end-to-end microbiome capacity

Arranta Bio announced the strengthening of its senior leadership team with the addition of David Stevens as Chief Operations Officer and Jason Rahal as Senior Vice President of Business Development.

January 30, 2020
·
4 min read
Business

Getinge Full Year Report 2019: Continued Growth, Higher Margins and Strengthened Cash Flow

“Our organic sales growth continued in the fourth quarter and it was particularly good to see the strong performance of our three largest markets - the US, China and Germany,” says Mattias Perjos, President & CEO at Getinge.

January 30, 2020
·
4 min read
Gene Expression Analysis Method has Been Validated by a Commercial Laboratory

Isofol Medical AB, announced that the method for gene expression analysis has been validated by a commercial laboratory, a request from regulatory authorities for use in clinical practice.

January 30, 2020
·
2 min read
Business

IRRAS: Q4 Report 2019 - Invitation to Conference Call and Audiocast

IRRAS will host a conference call and an online presentation of its Q4 2019 interim report.

January 30, 2020
·
1 min read
Biotech Bay

Astellas Submits Supplemental New Drug Application for Approval of Evrenzo® (roxadustat) for the Treatment of Anemia Associated with Chronic Kidney Disease in Non-Dialysis Dependent Patients in Japan

Astellas Pharma Inc. and FibroGen, Inc. announced the submission of a supplemental New Drug Application to Japan’s Ministry of Health, Labour and Welfare to gain marketing approval for Evrenzo® for the treatment of anemia associated with chronic kidney disease in non-dialysis dependent patients.

January 30, 2020
·
9 min read
Carbios Enters Joint Development Agreement With Novozymes to Produce Its Proprietary Enzyme for Complete Recycling of PET-plastics and Fibers

CARBIOS, a company pioneering new bio-industrial solutions to reinvent the lifecycle of plastic and textile polymers, announced an exclusive partnership with leading biological solutions company, Novozymes.

January 30, 2020
·
4 min read
Sensorion Presents New SENS-401 Preclinical Data at ARO Midwinter Meeting 2020

Poster and oral presentation highlight potential to significantly reduce hearing loss from chronic noise exposure in a rat model

January 30, 2020
·
6 min read